EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 11 February 2021

19 Conversations | The EFPIA podcast series

By Chris Skedgel (Office of Health Economics)

Today we're asking Chris Skedgel, Director at the Office of Health Economics:

"Can a shared understanding of unmet medical needs support innovation?".

Read more

News

Using the FMD Data Repositories for Shortages Monitoring
09 February 2021

Patient health and safety is of the utmost importance to the stakeholders that have put every effort in place to implement... Read more

EFPIA response to the Cross-border Healthcare Directive
09 February 2021

Giving patients access to safe and high-quality healthcare and encouraging cooperation across the European Union Read more

Videos

What do the different types of COVID-19 vaccine approvals mean?
With several COVID-19 vaccines approved across the EU, UK and USA, and more expected soon, Muriel Pasté, Head of Regulatory... Read more

#WeWontRest until we beat cancer
We are committed to working with all stakeholders to achieve tangible progress for today’s and tomorrow’s cancer patients,... Read more

Events

Unlocking the Potential of Precision Medicine in Europe
23 February 2021 (Virtual Event)

How to improve cancer care through broader access to quality biomarker testing Read more

Blueprint for Action on Diabetes in the European Union by 2030
25 February 2021 (Virtual Event)

MEPs Mobilising for Diabetes Webinar Read more

What we are reading

Myths of Vaccine Manufacturing
On 02 February 2021 (Science Translational Medicine)

Derek Lowe's commentary on drug discovery and the pharma industry. An editorially independent blog from the publishers... Read more

Pharma groups ‘losing time’ with EU export control mechanism
On 05 February 2021 (Euractiv)

Pharmaceutical companies have started experiencing delays in deliveries of vaccines and their components due to the... Read more

EU industry group warns new export rules threaten COVID-19 vaccine production and supply
On 08 February 2021 (BioPharma-Reporter.com)

EU pharma industry representatives have expressed concern that the recently enacted EU export transparency mechanism... Read more

Patents are not an obstacle to ramp up COVID-19 vaccines production, EU says
On 08 February 2021 (Euractiv)

The European Commission aims to ramp up production of COVID-19 vaccines through “voluntary” sharing of know-how among... Read more

Happy Anniversary EU FMD
On 09 February 2021 (Grant Courtney, via LinkedIn)

Two years ago, the EU Falsified Medicines Directive came into force introducing the most ambitious healthcare verification... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu